English Español

Bladder Cancer Advocacy Network Applauds Passage of the PACT Act of 2022

The Bladder Cancer Advocacy Network, BCAN, extends its thanks to the bipartisan members of the House and Senate for the passage of the PACT Act of 2022. 

“Veterans are disproportionately impacted by bladder cancer and we are pleased that, when signed into law, this legislation will help ease their burden,” said Andrea Maddox-Smith, Chief Executive Officer of the Bladder Cancer Advocacy Network. “Those who have served deserve better.”

This legislation extends protections to veterans who were exposed to toxins while serving our country.  Importantly, the bill establishes a presumption of eligibility for veterans with bladder cancer who were exposed to burn pit toxins.  Today, veterans afflicted by bladder cancer can have an uphill battle in receiving coverage for their treatments and the PACT Act rights that wrong.  Protecting our veterans impacted by this terrible disease is a priority for BCAN and we are pleased that Congress has advanced this legislation for the president’s signature.  

BCAN will continue to work with members of Congress of both political parties to advocate on behalf of bladder cancer patients to ensure greater public awareness and increased funding for for bladder cancer research.

The Bladder Cancer Advocacy Network’s (BCAN’s) mission is to increase public awareness about bladder cancer, advance bladder cancer research and provide educational and support services for the bladder cancer community.

For more information about veterans and bladder cancer, listen to this recent podcast with Dr. Joshua Meeks of the Jesse Brown VA Medical Center .

Contact:  Mark Story
Director of Communications and Marketing